Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
PHRX | CSE | CAD | Delayed | |
PHRX | CBOE Canada | CAD | Real-time |
Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally derived approved drugs. The company also engages in the researching and reformulating of established natural medicines; development of synthetic formulations of existing drugs for potential commercialization and distribution; development of cepharanthine, a drug for the treatment of infectious disease and rare cancers; and research and development activities in the psychedelics space for the treatment of non-neuropsychiatric conditions. It has a license agreement with Southwest Research Institute. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. Pharmadrug Inc. is based in Toronto, Canada.
Name | Age | Since | Title |
---|---|---|---|
Cindy Hutnik | - | 2021 | Member of Scientific & Clinical Advisory Board |
Terrance R. Booth | 59 | 2020 | Chairman of Advisory Board |
Steven A. Barker | 74 | 2021 | Member of Advisory Board |
Yelena Y. Janjigian | - | - | Member of Advisory Board |
Robert J. Steen | - | 2023 | CEO & Director |
Paul McClory | 80 | 2016 | Independent Director |
David M. Kideckel | 43 | 2021 | Independent Chairman of the Board |
Jimo Borjigin | - | - | Member of Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review